ASPIRIN TABLETS, USP

The Defense Logistics Agency awarded a firm-fixed-price delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for one bottle of ASPIRIN TABLETS, USP (NSN 6505001009985) at a unit price of $1.10, resulting in a total contract value of $1.10. The award was issued on July 17, 2026, with delivery scheduled for August 3, 2026, to Kadena Air Base, Okinawa, Japan, under FOB Destination terms, making the contractor responsible for all transportation costs. The item must conform to United States Pharmacopeia standards, and acceptance is performed by the Government at the destination. The procurement follows commercial item procedures under FAR 52.212-4 and FAR 52.212-5, with additional compliance requirements including FAR 52.222-50 on combating human trafficking. The awardee is identified as a small business eligible under the Women-Owned Small Business and Economically Disadvantaged WOSB set-aside programs, though no explicit certification documentation is included. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, with invoices submitted via standard DLA procedures, likely through WAWF. Administrative oversight is managed by Catherine Gilbert of DLA Troop Support in Philadelphia, while the contracting officer is Lorinda Ferraiolo. No packaging, preservation, or labeling specifications beyond standard NDC and CAGE code identification are detailed, and no military standards such as MIL-STD-129 or MIL-STD-2073 are cited. The contract contains no option periods, extended quantities, or special requirements beyond those inherent to commercial item procurement, and no evaluation factors or award basis are documented as the award appears to have been issued under a pre-established blanket purchase agreement with no competitive evaluation disclosed.